185 related articles for article (PubMed ID: 32909148)
1. Inhibition of lncRNA-UCA1 suppresses pituitary cancer cell growth and prolactin (PRL) secretion via attenuating glycolysis pathway.
Liu G; Wang L; Li Y
In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):642-649. PubMed ID: 32909148
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway.
Li Z; Li X; Wu S; Xue M; Chen W
Cancer Sci; 2014 Aug; 105(8):951-5. PubMed ID: 24890811
[TBL] [Abstract][Full Text] [Related]
4. Long non‑coding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer.
Fan L; Huang C; Li J; Gao T; Lin Z; Yao T
Int J Mol Med; 2018 Oct; 42(4):2247-2259. PubMed ID: 30015920
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA UCA1 regulates CCR7 expression to promote tongue squamous cell carcinoma progression by sponging miR-138-5p.
Shi TT; Li R; Zhao L
Neoplasma; 2020 Nov; 67(6):1256-1265. PubMed ID: 32749849
[TBL] [Abstract][Full Text] [Related]
6. Suppression of long non-coding RNA UCA1 inhibits proliferation and invasion and induces apoptosis in human lung cancer cells.
Jun T; Zheng FS; Ren KM; Zhang HY; Zhao JG; Zhao JZ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7274-7281. PubMed ID: 30468471
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of long non-coding RNA urothelial carcinoma associated 1 causes paclitaxel (Taxol) resistance in colorectal cancer cells by promoting glycolysis.
Shi H; Li K; Feng J; Zhang X
J Chemother; 2021 Oct; 33(6):409-419. PubMed ID: 33818320
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1 upregulates the expression of lncRNA UCA1 and its downstream HXK2 to promote the growth of hepatocellular carcinoma.
Hu ML; Wang XY; Chen WM
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4846-4854. PubMed ID: 30070319
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.
Xue M; Chen W; Xiang A; Wang R; Chen H; Pan J; Pang H; An H; Wang X; Hou H; Li X
Mol Cancer; 2017 Aug; 16(1):143. PubMed ID: 28841829
[TBL] [Abstract][Full Text] [Related]
10. RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.
D'Angelo D; Mussnich P; Sepe R; Raia M; Del Vecchio L; Cappabianca P; Pellecchia S; Petrosino S; Saggio S; Solari D; Fraggetta F; Fusco A
J Mol Med (Berl); 2019 Jul; 97(7):1019-1032. PubMed ID: 31076808
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
12. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma.
Zhao W; Sun C; Cui Z
Clin Transl Oncol; 2017 Jun; 19(6):735-741. PubMed ID: 28105536
[TBL] [Abstract][Full Text] [Related]
13. Effect of lncRNA HULC knockdown on rat secreting pituitary adenoma GH3 cells.
Rui QH; Ma JB; Liao YF; Dai JH; Cai ZY
Braz J Med Biol Res; 2019; 52(4):e7728. PubMed ID: 30994730
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Li JY; Ma X; Zhang CB
Int J Clin Exp Pathol; 2014; 7(11):7938-44. PubMed ID: 25550835
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA UCA1 regulates the proliferation, migration and invasion of human lung cancer cells by modulating the expression of microRNA-143.
Jun T; Zheng FS; Ren KM; Zhang HY; Zhao JG; Zhao JZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8343-8352. PubMed ID: 30556875
[TBL] [Abstract][Full Text] [Related]
16. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
Wang F; Ying HQ; He BS; Pan YQ; Deng QW; Sun HL; Chen J; Liu X; Wang SK
Oncotarget; 2015 Apr; 6(10):7899-917. PubMed ID: 25760077
[TBL] [Abstract][Full Text] [Related]
17. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
18. HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.
Li T; Xiao Y; Huang T
Oncol Rep; 2018 Mar; 39(3):1072-1080. PubMed ID: 29328452
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.
Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X
PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
